UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

An Optimized Melanin Depigmentation Method for Histopathological and Immunohistochemical Staining of Formalin-Fixed Paraffin-Embedded Tissues

International journal of surgical pathology, 2024-06, Vol.32 (4), p.679-683

2024

Volltextzugriff (PDF)

Vascular adhesion protein‐1 as indicator of breast cancer tumor aggressiveness and invasiveness

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2018-09, Vol.126 (9), p.755-761

2018

Volltextzugriff (PDF)

Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer

Biomedicine & pharmacotherapy, 2023-07, Vol.163, p.114732-114732, Article 114732

2023

Volltextzugriff (PDF)

The Diagnostic Significance of CXCL13 in M2 Tumor Immune Microenvironment of Human Astrocytoma

Pathology oncology research, 2022-04, Vol.28, p.1610230

2022

Volltextzugriff (PDF)

CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells

Experimental cell research, 2018-02, Vol.363 (1), p.65-72

2018

Volltextzugriff (PDF)

Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer

International journal of molecular sciences, 2021-02, Vol.22 (5), p.2402

2021

Volltextzugriff (PDF)

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer

International journal of molecular sciences, 2016-08, Vol.17 (9), p.1432

2016

Volltextzugriff (PDF)

FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer

Biomedicines, 2021-11, Vol.9 (12), p.1789

2021

Volltextzugriff (PDF)

Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer

Cancers, 2019-12, Vol.12 (1), p.94

2019

Volltextzugriff (PDF)

Non-Hodgkin Lymphoma Metabolism

Advances in experimental medicine and biology, 2021, Vol.1311, p.103

2021

Volltextzugriff (PDF)

Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas

Diagnostics (Basel), 2020-04, Vol.10 (5), p.256

2020

Volltextzugriff (PDF)

Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2016-06, Vol.124 (6), p.462-468

2016

Volltextzugriff (PDF)

Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24−/low) indicate poor prognosis in triple-negative breast cancer

Human pathology, 2016-02, Vol.48, p.48-55

2016

Volltextzugriff (PDF)

FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer

Journal of clinical medicine, 2019-01, Vol.8 (1), p.38

2019

Volltextzugriff (PDF)

Non-Hodgkin Lymphoma Metabolism

Advances in experimental medicine and biology, 2018, Vol.1063, p.95

2018

Volltextzugriff (PDF)

CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma

Pathology, research and practice, 2022-12, Vol.240, p.154173, Article 154173

2022

Volltextzugriff (PDF)

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics

Life sciences (1973), 2019-12, Vol.238, p.116963-116963, Article 116963

2019

Volltextzugriff (PDF)

BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer

Radiotherapy and oncology, 2020-08, Vol.149, p.249-258

2020

Volltextzugriff (PDF)

CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer

International journal of biological sciences, 2021-01, Vol.17 (7), p.1660-1670

2021

Volltextzugriff (PDF)

Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94

Cancers, 2021-10, Vol.13 (21), p.5401

2021

Volltextzugriff (PDF)

Arsenic-induced disruption of circadian rhythms and glutamine anaplerosis in human urothelial carcinoma

Journal of trace elements in medicine and biology, 2024-12, Vol.86, p.127507, Article 127507

2024

Volltextzugriff (PDF)

Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer

Life sciences (1973), 2024-09, Vol.353, p.122914, Article 122914

2024

Volltextzugriff (PDF)

Corrigendum to: “BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer” [Radiother Oncol 149 (2020) 249–258]

Radiotherapy and oncology, 2021-10, Vol.163, p.247-248

2021

Volltextzugriff (PDF)

beta 1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer

International journal of molecular sciences, 2016-09, Vol.17 (9), p.1432-1432

2016

Volltextzugriff (PDF)

Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer

Cancer genomics & proteomics, 2024-09, Vol.21 (5), p.523-532

2024

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(23)
Humans
(16)
Breast Cancer
(7)
Medicine, Research & Experimental
(7)
Research & Experimental Medicine
(7)
Triple-Negative Breast Cancer
(7)
Female
(6)
Gene Expression
(6)
Immunohistochemistry
(6)
Metastases
(6)
Metastasis
(6)
Oncology
(6)
Pathology
(6)
Pharmacology & Pharmacy
(6)
Biochemistry & Molecular Biology
(5)
Biomarkers
(5)
Prognosis
(5)
Proteins
(5)
Triple Negative Breast Neoplasms - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

An Optimized Melanin Depigmentation Method for Histopathological and Immunohistochemical Staining of Formalin-Fixed Paraffin-Embedded Tissues

Vascular adhesion protein‐1 as indicator of breast cancer tumor aggressiveness and invasiveness

Combination of FAK inhibitor and cytokine-induced killer cell therapy: An alternative therapeutic strategy for patients with triple-negative breast cancer

The Diagnostic Significance of CXCL13 in M2 Tumor Immune Microenvironment of Human Astrocytoma

CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells

Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer

FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer

Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer

Non-Hodgkin Lymphoma Metabolism

Increased Vascular Adhesion Protein 1 (VAP-1) Levels are Associated with Alternative M2 Macrophage Activation and Poor Prognosis for Human Gliomas

Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas

Decreased expression of autophagy protein LC3 and stemness (CD44+/CD24−/low) indicate poor prognosis in triple-negative breast cancer

FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer

Non-Hodgkin Lymphoma Metabolism

CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics

BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer

CHD4 as an important mediator in regulating the malignant behaviors of colorectal cancer

Correction: Pan et al. Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer. Cancers 2020, 12, 94

Arsenic-induced disruption of circadian rhythms and glutamine anaplerosis in human urothelial carcinoma

Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer

Corrigendum to: “BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer” [Radiother Oncol 149 (2020) 249–258]

beta 1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer

Targeting Bmi1 for Enhancing Anoikis Sensitivity and Inhibiting Metastasis in Colorectal Cancer

Suchergebnisse filtern